Figure 7
Figure 7. DCs derived from HTLV-1–infected individuals have a reduced capacity for activation in vitro. Cells were incubated with IL-4 plus GM-CSF (50 ng/mL) for 5 days at 37°C in a 5% CO2 atmosphere. After this period, cells were incubated in the presence or absence of TNF-α for 48 hours at 37°C in a 5% CO2 atmosphere. After 7 days, CD83, CD86, and HLA-DR expression was analyzed by flow cytometry. Data in bars are expressed as percentage of CD14−CD83+ cells (A), CD14−CD86+ cells (B), or CD14−HLA-DR+ cells (C). Open bars represent cells obtained from noninfected donors (CTR; n = 10), and shaded bars represent cells obtained from HTLV-1–infected donors (n = 12). Data are mean ± SD of 9 independent experiments. * and ** Indicate significantly different from DCs unstimulated with TNF-α (P < .05). (D) Representative experiment showing CD83, CD86, and HLA-DR expression patterns in cells from noninfected and HTLV-1–infected donors (region M2 comprises positive cells).

DCs derived from HTLV-1–infected individuals have a reduced capacity for activation in vitro. Cells were incubated with IL-4 plus GM-CSF (50 ng/mL) for 5 days at 37°C in a 5% CO2 atmosphere. After this period, cells were incubated in the presence or absence of TNF-α for 48 hours at 37°C in a 5% CO2 atmosphere. After 7 days, CD83, CD86, and HLA-DR expression was analyzed by flow cytometry. Data in bars are expressed as percentage of CD14CD83+ cells (A), CD14CD86+ cells (B), or CD14HLA-DR+ cells (C). Open bars represent cells obtained from noninfected donors (CTR; n = 10), and shaded bars represent cells obtained from HTLV-1–infected donors (n = 12). Data are mean ± SD of 9 independent experiments. * and ** Indicate significantly different from DCs unstimulated with TNF-α (P < .05). (D) Representative experiment showing CD83, CD86, and HLA-DR expression patterns in cells from noninfected and HTLV-1–infected donors (region M2 comprises positive cells).

Close Modal

or Create an Account

Close Modal
Close Modal